Patients vote with their feet for 'On demand' rabeprazole in the maintenance treatment phase of reflux oesophagitis

Aliment Pharmacol Ther. 2010 Jul;32(2):305-7; author reply 307-8. doi: 10.1111/j.1365-2036.2010.04333.x.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles / therapeutic use*
  • Anti-Ulcer Agents / therapeutic use*
  • Esophagitis, Peptic / drug therapy*
  • Health Care Costs
  • Humans
  • Patient Compliance
  • Rabeprazole

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Rabeprazole